Depressive symptoms in first episode schizophrenia spectrum disorder
SM Cotton, M Lambert, BG Schimmelmann, A Mackinnon, JFM Gleeson, M Berk, L Hides, A Chanen, PD McGorry, P Conus
Schizophrenia Research | ELSEVIER | Published : 2012
The First Episode Outcome Study (FEPOS) was supported by a grant to Prof. Martin Lambert from Eli Lilly Company Australia, and a grant to Prof. Philippe Corms from the Leenaards Foundation, Switzerland. Eli Lilly Australia funded the assessment of files on a subgroup of this cohort treated with olanzapine and risperidone. Associate Prof. Sue Cotton is supported by the Ronald Phillip Griffith Fellowship, Faculty of Medicine, Dentistry, and Health Sciences, The University of Melbourne.